1. From the Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland; the
2. National Vaccine Injury Compensation Program, Health Resources and Services Administration, Department of Health and Human Services, Rockville, Maryland; and the
3. School of Public Policy, Georgia Institute of Technology, Atlanta, Georgia.